Among 13 kinds of tumors, STAT1, IFNG, and CCR5 showed low methylation levels in BRCA, KIRC, LIHC, HNSC, UCEC, and BLCA (Figure 3A). This evidence concerns the gene CCR5 and bladder transitional cell carcinoma.